Turkish Journal of Medical Sciences
Volume 28

Number 1

Article 17

1-1-1998

Prevalence of Rheumatoid Factor (RF) andAnti-native-DNA
Antibodies (anti-n DNA) inDifferent Age Subpopulations
Fatoş ÖNEN
Cansel TÜRKAY
Ali MEYDAN
H. Sebila DÖKMETAŞ
Haldun SÜMER

See next page for additional authors

Follow this and additional works at: https://journals.tubitak.gov.tr/medical
Part of the Medical Sciences Commons

Recommended Citation
ÖNEN, Fatoş; TÜRKAY, Cansel; MEYDAN, Ali; DÖKMETAŞ, H. Sebila; SÜMER, Haldun; HOCAOĞLU, Lütfi;
IÇAGASIOĞLU, Serhat; and BAKICI, M. Zahir (1998) "Prevalence of Rheumatoid Factor (RF) andAnti-nativeDNA Antibodies (anti-n DNA) inDifferent Age Subpopulations," Turkish Journal of Medical Sciences: Vol.
28: No. 1, Article 17. Available at: https://journals.tubitak.gov.tr/medical/vol28/iss1/17

This Article is brought to you for free and open access by TÜBİTAK Academic Journals. It has been accepted for
inclusion in Turkish Journal of Medical Sciences by an authorized editor of TÜBİTAK Academic Journals. For more
information, please contact academic.publications@tubitak.gov.tr.

Prevalence of Rheumatoid Factor (RF) andAnti-native-DNA Antibodies (anti-n
DNA) inDifferent Age Subpopulations
Authors
Fatoş ÖNEN, Cansel TÜRKAY, Ali MEYDAN, H. Sebila DÖKMETAŞ, Haldun SÜMER, Lütfi HOCAOĞLU,
Serhat IÇAGASIOĞLU, and M. Zahir BAKICI

This article is available in Turkish Journal of Medical Sciences: https://journals.tubitak.gov.tr/medical/vol28/iss1/17

Tr. J. of Medical Sciences
28 (1998) 85-88
© TÜBİTAK

F. ÖNEN, C. TÜRKAY, A. MEYDAN, H. S. DÖKMETAŞ, H. SÜMER, L. HOCAOĞLU, S. İÇAĞASIOĞLU, M. Z. BAKICI

Fatoş ÖNEN1
Cansel TÜRKAY1
Ali MEYDAN1
H. Sebila DÖKMETAŞ1
Haldun SÜMER2
Lütfi HOCAOĞLU1
Serhat İÇAĞASIOĞLU1
M. Zahir BAKICI3

Prevalence of Rheumatoid Factor (RF) and
Anti-native-DNA Antibodies (anti-n DNA) in
Different Age Subpopulations

Received: July 22, 1996

Abstract: In this study, we have evaluated
the prevalence of RF and anti-n-DNA in different age subpopulations grouped according
to their clinical status.
RF and anti-n-DNA were measured in the serum of 51 elderly people considered to be successfully aging (group 1), 65 chronically ill
elderly (group 2), 65 chronically ill patients
under 65 years (group 3) and 30 patients
with rheumatoid arthritis (group 4). The results were compared to 100 healthy persons
as a control group under 65 years.
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The prevalences of RF in group 1, group 2
and group 3 were significantly higher than
the healthy younger controls. Particularly the
difference between group 2 and the control
group was markedly significant (p<0.001).
There was not any difference between group

Introduction
Several autoantibodies have predictive diagnostic
values for connective tissue diseases (CTD). Two of
them, RF and anti-n DNA are often used in the practice of Rheumatology. RF is detected in 70 % of patients with rheumatoid arthritis (RA) (1). Anti-n DNA
has high specificity for patients with SLE (2, 3).
It is known that the prevalence of RF is increased
in elderly and is some diseases other than RA (1, 46). When the recent literature was reviewed, variable
reporting of the prevalence of autoantibodies in aged
populations were seen (3, 4, 7-12). The selection of
subjects to be studied may be responsible for these
variable reports.
To determine the effect of age and chronic illness
on the prevalence of RF and anti- n DNA, we performed this study in individuals with different age and
clinical status.

1 and 2.
In multiple logistic regression analysis, we
found significant relationship between RF
positivity and chronic illness and also being
elderly (r=0.18, p<0.01 and r=0.14
p<0.05). When being elderly factor was added to the analysis of relationship of RF and
chronic illness, it was seen that the relation
diminished but persisted (r=0.11, p<0.05).
None of the patients in our study groups had
antibodies to n-DNA.
In conclusion, we suggest that the prevalence
of RF rises in both chronic illness and being
elderly, but chronic illness is more effective
on the RF positivity than being elderly.
Key Words: Rheumatoid factor, anti-nativeDNA antibodies, elderly, chronic illness.

Materials and Methods
Five groups were studied:
Group 1 consisted of 51 “successfully aging elderly” (13) subjects (24 women and 27 men), in the
range of 65 to 90 years (mean 72.06±1.04). They
were from the rest home or were ambulatory volunteers who had no history of chronic illness, no regular medication intake and no clinical or laboratory evidence of acute and chronic illness.
Group 2 included 65 chronically ill patients (34
women and 31 men), in the age range of 65 to 93
years (mean 68.85±0.77). They had variable nonrheumatologic chronic illness such as diabetes mellitus,
hypertension, coronary artery disease and chronic liver
disease.
In group 3, there were 65 chronically ill patients
(30 women and 35 men), in the range of 17 to 65
years (mean 42.25±0.77), who had variable chronic
illness similar to those in group 2.
Group 4 consisted of 30 patients with RA (26
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women and 6 men), in the range of 34 to 69 years
(mean 55.23±2.11) and who fulfilled the criteria of
the American Rheumatism Association (14).

The prevalence of the RF and anti –n DNA in the
four study groups and healthy young controls are presented in the table.

The RF and anti-n DNA results of these groups
were compared to 100 healthy younger controls (54
women and 46 men) in the range of 17 to 65 years
(mean 32.55±0.95).

In the multiple logistic regression analysis, we
found significant relationship between RF positivity and
chronic illness and also elderly (r=0.18, p<0.01 and
r=0.14, p<0.05 respectively). When elderly factor was
added to the analysis of relationship of RF and chronic
illness, it was seen that although the relation diminished it persisted (r=0.11, p<0.05).

Sera from all subjects were analyzed in the same
laboratory using the standardized techniques.
IgM RF was measured using a commercially available kit assay (RapiTex RF, Behring Diagnostic Inc.,
Westwood, USA). This was a rapid slide latex agglutination test for the qualitative and semiquantitative
measurement of rheumatoid factor in human serum. A
positive result was confirmed when agglutination occurred with RF latex reagent mixed with sera containing greater than 19 IU/ml of RF.
Anti-n-DNA Quick Test (Human Gesellschaft für Biochemica und Diagnostica mbH, Germany) was used to
examine the presence of anti-n-DNA. This test is based
on the following principle: Latex particles are bound
with native deoxyribonucleic acid (n-DNA) by means of
an intermediary albumin matrix. These coated latex
particles combine with any antibodies to n-DNA in serum to give a visible agglutination. The test was considered as negative when no difference in agglutination
was observed between specimen and negative control.
The positive control and positive sera have shown distinct agglutination within 2 minutes.
Fisher’s Exact Test and Multiple Logistic Regression
Analysis were used for evaluation the statistical significance.
Results
The prevalence of RF in the successfully aging elderly (group 1), chronically ill elderly (group 2) and
chronically ill aged under 65 (group 3) patients were
found as 11.8 %, 21.5 % and 13.8 % respectively.
These results were significantly higher than healthy
younger controls (3 %). Particularly the difference between group 2 and the control group was markedly
significant (p<0.001). There was not any difference
between group 1 and 2 (p>0.05). The prevalence of
RF in the chronically ill elderly patients was also higher than the chronically ill younger patients. Subjects
with RA had a 76.7% prevalence of positive RF.
No individual in our study grups had anti-n DNA
antibodies.
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Discussion
The prevalence of autoantibodies in elderly populations has been reported to be increased compared to
that seen in younger populations (4, 5, 8, 10). This
increase has been attributed to effect of progressive
senescence of immune function (7) and it has been believed that serologic tests were not diagnostic because
of false positive results were common in healthy elderly subjects (15). In contrast, it has been shown that
prevalence of autoantibodies decresaed in elderly persons with rheumatological disease (11, 12, 16).
Therefore the belief that aging in humans is accompanied by increased autoantibodies may not be always right. A review of the recent literature reveals
variable reporting of the prevalence of autoantibodies
in aged people (4, 7-12). In these studies, various
clinical and laboratory criteria have been applied for
patient selection. We must recognize that there is an
important but often difficult distinction to be made between changes in all systems of human organism due
to the normal process of senescence and those abnormal changes attributable, in part, to disease. And
also it must be considered that significant heterogeneity of elderly populations are seen in different
studies, so this may contribute to false results.
In 1984, the SENIEUR protocol was described as a
method of selection of the subjects to be studied in
immunogerontologic studies (17). In this protocol
many non-specific disease-associated changes may be
inappropriately attributed to the aging process.
Normal aging may be categorized into two groups:
Usual and successful aging. In first of them, extrinsic
factors heighten the effects of aging alone and in the
second, extrinsic factors play a neutral or postive role
(13). Previous studies have been usually performed
only on chronically ill aged patients and have been excluded the healthy elderly people. In recent years, successfully aging subgroups were also studied in these
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researches. Juby et al (9) reported that successfully
aging individuals had a prevalence of RF and FANA
which were not statistically significantly higher than a
healthy young adult control group. They also found
that patients with chronic illness had a markedly increased prevalence of RF which was statistically significant than both of the healthy elderly and the
young control group.
Table

RF and anti-n-DNA prevalence in the study groups and the
control group

n

RF(ê) (%)

Anti-n DNA(+)

Group 1

51*

6(11.8)

0

Group 2

65**

14(21.5)

0

Group 3

63*

9(13.8)

0

Group 4

30

23(76.7)

0

Controls

100

3(3)

0

*
**

p<0.05 Group 1 or 3 v controls
p<0.001 Group 2 v controls

We determined that the prevalence of RF in our
successfully aging elderly group was significantly higher than the younger healthy controls, and the presence
of chronic illness increased the prevalence of RF independent of age. Chronic illness was found to be
more effective on the prevalence of RF than being elderly. Although successfully aging elderly had no history
of chronic illness, no regular medication intake and no
clinical or laboratory evidence of acute and chronic illness, they could have been exposed to an agent(s)
which no longer exists today. Thus the higher titers
among the elderly may not to be due to the aging per
se but to a “cohort effect”. The prevalence of RF in
our RA patients was similar to those in other published reports (1).
Silvestris et al (7) had also shown that sera of eld-

erly subjects contained statistically significantly higher
amounts of lgM RF than young controls and the levels
of anti-DNA were similar in both groups. In a crosssectional study of 100 healthy elderly individuals, significant titers of lgM RF have been found in 10 %.
Antibodies to single or double stranded DNA were not
detected in any subjects (5). This paradoxical dissociation of the RF from the other levels of autoantibodies in elderly population could suggest a different significance of lgM RF which may be distinct from
the anti-n DNA. In many healthy elderly people, the
increased production of lgM RF may not be an expression of the general increase of autoimmune phenomena.
It has been found that the size of self-reactive B
cell pool which synthezing RF increased with advancing
age (6). This finding suggests that RF may play a
physiologic role in the immune response.
There are variable reports about autoantibodies in
the elderly with rheumatic disease as well as in
healthy elderly (3, 11, 12, 16, 18).
We found that antibodies to n-DNA did not occur
in any of our groups similar to Chakravarty et al (5).
Some investigators reported that anti-double-stranded
antibodies were found in healthy aged people (4, 8,
10), but this peculiar antibody differed from those
found in patients with SLE with having low titers, belonging to the lgA class alone, negativity to Farr assay
and no complement-fixing ability (4,10). Methodological differences may account for differences in reporting of prevalence of anti-n antibodies in elderly.
We know that anti-n DNA has high specificity for patients with SLE (2, 3). We think that, as there were
not any SLE patient in our study groups, all of them
had negative anti-n DNA.
In conclusion, we suggested that the inclusion of
subjects
of
successfully
aging
in
the
immunogerontologic studies is necessary for more correct results and this approach provides determining
the clinical significance of autoantibodies in elderly
people.
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